Jarol, Alkhalid P.
HRN: 18-60-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/27/2022
12/04/2022
IVT
585 Mg
8 Hrs
BFC; T/c UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes